Chief Scientific Officer and Professor of Immunology
Innate Pharma and AP-HM, Aix-Marseille University, Centre for Immunology of Marseille-Luminy (CIML)
Marseille, Provence-Alpes-Cote d'Azur, France
Éric Vivier, DVM, PhD, is Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille (AP-HM). In addition, he is a co-founder and Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic antibodies that exploit the immune system.
He completed his post-doctoral training at Harvard Medical School, then joined Aix-Marseille University as professor at the Centre d'Immunologie de Marseille-Luminy (CIML) in 1993 before becoming its director from 2008 to 2017. He is also the President of the Paris Saclay Cancer Cluster, a biocluster dedicated to accelerate the developement of innovative solutions in cancer.
Eric Vivier's work focuses on innate immunity and in particular Natural killer and other innate lymphoid cells, at Ciml, at AP-HM and at Innate-Pharma. Professor Vivier has published over 400 scientific articles and is on the list of the most cited researchers. scholar.google.fr/citations?user=NlmFOgMAAAAJ&hl=fr&oi=ao
A laureate of the European Research Council (ERC advanced grants), a member of the EMBO, the Académie Nationale de Médecine and the Institut Universitaire de France, Prof. Vivier has received several awards including those from the Ligue Nationale contre le Cancer and from the European Federation of Immunological Societies (EFIS).
He is Chevalier de la Légion d’Honneur and Officier de l’Ordre National du Mérite, and Ordre national des Palmes Académiques.
Disclosure information not submitted.
Harnessing Innate Immunity in Cancer Therapy
Wednesday, June 25, 2025
10:00am - 10:30am East Coast USA Time
